American Association for the Advancement of Science, Science Translational Medicine, 559(12), 2020
DOI: 10.1126/scitranslmed.abc3103
Full text: Unavailable
Different serological assays measuring anti–SARS-CoV-2 antibodies and their neutralizing activity in samples from individuals with severe and mild COVID-19 are compared.